These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7615015)

  • 21. Characterization of apolipoprotein J-Alzheimer's A beta interaction.
    Matsubara E; Frangione B; Ghiso J
    J Biol Chem; 1995 Mar; 270(13):7563-7. PubMed ID: 7706304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels of the senescence biomarker clusterin/apolipoprotein J increase significantly in diabetes type II and during development of coronary heart disease or at myocardial infarction.
    Trougakos IP; Poulakou M; Stathatos M; Chalikia A; Melidonis A; Gonos ES
    Exp Gerontol; 2002; 37(10-11):1175-87. PubMed ID: 12470829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predominant apolipoprotein J exists as lipid-poor mixtures in cerebrospinal fluid.
    Suzuki T; Tozuka M; Kazuyoshi Y; Sugano M; Nakabayashi T; Okumura N; Hidaka H; Katsuyama T; Higuchi K
    Ann Clin Lab Sci; 2002; 32(4):369-76. PubMed ID: 12458888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers.
    Zlokovic BV; Martel CL; Matsubara E; McComb JG; Zheng G; McCluskey RT; Frangione B; Ghiso J
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4229-34. PubMed ID: 8633046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of IGF-I and -II, IGF binding proteins (IGFBPs) and IGFBP mRNA in ocular fluids and tissues: potential sites of synthesis of IGFBPs in aqueous and vitreous.
    Arnold DR; Moshayedi P; Schoen TJ; Jones BE; Chader GJ; Waldbillig RJ
    Exp Eye Res; 1993 May; 56(5):555-65. PubMed ID: 7684697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification and characterization of apolipoprotein J.
    de Silva HV; Stuart WD; Park YB; Mao SJ; Gil CM; Wetterau JR; Busch SJ; Harmony JA
    J Biol Chem; 1990 Aug; 265(24):14292-7. PubMed ID: 2387851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure and stability of apolipoprotein J-containing high-density lipoproteins.
    Stuart WD; Krol B; Jenkins SH; Harmony JA
    Biochemistry; 1992 Sep; 31(36):8552-9. PubMed ID: 1390641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Localization of myocilin/trabecular meshwork--inducible glucocorticoid response protein in the human eye.
    Karali A; Russell P; Stefani FH; Tamm ER
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):729-40. PubMed ID: 10711688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clusterin/apolipoprotein J in human aging and cancer.
    Trougakos IP; Gonos ES
    Int J Biochem Cell Biol; 2002 Nov; 34(11):1430-48. PubMed ID: 12200037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor beta (TGF beta)-induced nuclear localization of apolipoprotein J/clusterin in epithelial cells.
    Reddy KB; Jin G; Karode MC; Harmony JA; Howe PH
    Biochemistry; 1996 May; 35(19):6157-63. PubMed ID: 8634259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoproteins J and E co-localise with amyloid in gelatinous drop-like and lattice type I corneal dystrophies.
    Nishida K; Quantock AJ; Dota A; Choi-Miura NH; Kinoshita S
    Br J Ophthalmol; 1999 Oct; 83(10):1178-82. PubMed ID: 10502582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein J: structure and tissue distribution.
    de Silva HV; Harmony JA; Stuart WD; Gil CM; Robbins J
    Biochemistry; 1990 Jun; 29(22):5380-9. PubMed ID: 1974459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microglial apolipoprotein E and astroglial apolipoprotein J expression in vitro: opposite effects of lipopolysaccharide.
    Saura J; Petegnief V; Wu X; Liang Y; Paul SM
    J Neurochem; 2003 Jun; 85(6):1455-67. PubMed ID: 12787065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiological chemistry of the eye.
    Barber GW
    Arch Ophthalmol; 1973 Mar; 89(3):236-55. PubMed ID: 4120600
    [No Abstract]   [Full Text] [Related]  

  • 35. Apolipoprotein J (clusterin) and Alzheimer's disease.
    Calero M; Rostagno A; Matsubara E; Zlokovic B; Frangione B; Ghiso J
    Microsc Res Tech; 2000 Aug; 50(4):305-15. PubMed ID: 10936885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.
    Navab M; Hama-Levy S; Van Lenten BJ; Fonarow GC; Cardinez CJ; Castellani LW; Brennan ML; Lusis AJ; Fogelman AM; La Du BN
    J Clin Invest; 1997 Apr; 99(8):2005-19. PubMed ID: 9109446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein J inhibits the migration, adhesion, and proliferation of vascular smooth muscle cells.
    Sivamurthy N; Stone DH; Logerfo FW; Quist WC
    J Vasc Surg; 2001 Oct; 34(4):716-23. PubMed ID: 11668329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular fluid ferning test and fractals.
    Battaglia Parodi M; Giusto DD
    Ophthalmic Res; 1993; 25(5):307-13. PubMed ID: 8259264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification and characterization of brain clusterin.
    Oda T; Pasinetti GM; Osterburg HH; Anderson C; Johnson SA; Finch CE
    Biochem Biophys Res Commun; 1994 Nov; 204(3):1131-6. PubMed ID: 7980587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal distribution of retinal clusterin in retinitis pigmentosa.
    Jomary C; Murphy BF; Neal MJ; Jones SE
    Brain Res Mol Brain Res; 1993 Nov; 20(3):274-8. PubMed ID: 8302166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.